{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T17:26:58Z","timestamp":1790011618452,"version":"4.0.1"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.jpsychires.2024.01.002","type":"journal-article","created":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T10:32:46Z","timestamp":1704277966000},"page":"297-301","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Relationship between C-reactive protein and antipsychotics levels in schizophrenic patients infected with COVID-19"],"prefix":"10.1016","volume":"170","author":[{"given":"Shujuan","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanli","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangfang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaxue","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingxu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menghan","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonggang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingjie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junchao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kebing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3522-3912","authenticated-orcid":false,"given":"Yunlong","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpsychires.2024.01.002_bib1","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev.pharmtox.46.120604.141059","article-title":"Regulation of drug-metabolizing enzymes and transporters in inflammation","volume":"46","author":"Aitken","year":"2006","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.jpsychires.2024.01.002_bib2","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jpsychires.2024.01.002_bib3","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.schres.2017.03.045","article-title":"Elevated clozapine levels associated with infection: a systematic review","volume":"192","author":"Clark","year":"2018","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jpsychires.2024.01.002_bib4","doi-asserted-by":"crossref","first-page":"930","DOI":"10.2174\/138920012802138642","article-title":"Effects of interleukin 1beta (IL-1beta) and IL-1beta\/interleukin 6 (IL-6) combinations on drug metabolizing enzymes in human hepatocyte culture","volume":"13","author":"Dickmann","year":"2012","journal-title":"Curr. Drug Metabol."},{"key":"10.1016\/j.jpsychires.2024.01.002_bib5","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.ejps.2003.09.010","article-title":"CYP1A2 activity is an important determinant of clozapine dosage in schizophrenic patients","volume":"20","author":"Doude van Troostwijk","year":"2003","journal-title":"Eur. J. Pharmaceut. Sci. Offic. J. Eur. Fed. Pharmaceut. Sci."},{"key":"10.1016\/j.jpsychires.2024.01.002_bib6","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/cpt.2432","article-title":"Clinical and molecular perspectives on inflammation-mediated regulation of drug metabolism and transport","volume":"112","author":"Dunvald","year":"2022","journal-title":"Clin. Pharmacol. Therapeut."},{"key":"10.1016\/j.jpsychires.2024.01.002_bib7","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.schres.2022.01.049","article-title":"Association between C-reactive protein levels and antipsychotic treatment during 12 months follow-up period after acute psychosis","volume":"241","author":"Fathian","year":"2022","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jpsychires.2024.01.002_bib8","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jpsychires.2024.01.002_bib9","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1007\/s00213-015-3976-0","article-title":"Inflammation and psychotropic drugs: the relationship between C-reactive protein and antipsychotic drug levels","volume":"233","author":"Hefner","year":"2016","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jpsychires.2024.01.002_bib10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1055\/s-0043-116492","article-title":"Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: update 2017","volume":"51","author":"Hiemke","year":"2018","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.jpsychires.2024.01.002_bib11","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1081\/DMR-100101906","article-title":"Modulation of drug metabolism in infectious and inflammatory diseases","volume":"31","author":"Iber","year":"1999","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.jpsychires.2024.01.002_bib12","first-page":"e316","article-title":"Causes and outcomes of markedly elevated C-reactive protein levels","volume":"63","author":"Landry","year":"2017","journal-title":"Can. Fam. Physician Medecin de famille canadien"},{"key":"10.1016\/j.jpsychires.2024.01.002_bib13","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/jmv.25757","article-title":"COVID-19 patients' clinical characteristics, discharge rate, and fatality rate of meta-analysis","volume":"92","author":"Li","year":"2020","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.jpsychires.2024.01.002_bib14","first-page":"207","article-title":"Regulation of cytochrome p450 by inflammatory mediators: why and how?","volume":"29","author":"Morgan","year":"2001","journal-title":"Drug Metabol. Dispos.: Biol. Fate. Chem."},{"key":"10.1016\/j.jpsychires.2024.01.002_bib15","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1124\/dmd.107.018747","article-title":"Regulation of drug-metabolizing enzymes and transporters in infection, inflammation, and cancer","volume":"36","author":"Morgan","year":"2008","journal-title":"Drug Metabol. Dispos.: Biol. Fate. Chem."},{"key":"10.1016\/j.jpsychires.2024.01.002_bib16","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1211\/jpp.58.7.0001","article-title":"Role of CYP pharmacogenetics and drug-drug interactions in the efficacy and safety of atypical and other antipsychotic agents","volume":"58","author":"Murray","year":"2006","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jpsychires.2024.01.002_bib17","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1177\/00912700122010717","article-title":"Contributions of five human cytochrome P450 isoforms to the N-demethylation of clozapine in vitro at low and high concentrations","volume":"41","author":"Olesen","year":"2001","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.jpsychires.2024.01.002_bib18","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1124\/mi.7.2.10","article-title":"Regulation of drug transporters during infection and inflammation","volume":"7","author":"Petrovic","year":"2007","journal-title":"Mol. Interv."},{"key":"10.1016\/j.jpsychires.2024.01.002_bib19","doi-asserted-by":"crossref","DOI":"10.1080\/15321819.2021.1951291","article-title":"COVID-19: clinical presentation and detection methods","volume":"43","author":"Pradhan","year":"2022","journal-title":"J. Immunoassay Immunochem."},{"key":"10.1016\/j.jpsychires.2024.01.002_bib20","first-page":"99","article-title":"Interactions between the cytochrome P450 system and the second-generation antipsychotics","volume":"28","author":"Prior","year":"2003","journal-title":"J. Psychiatr. Neurosci. : J. Psychiatr. Neurosci."},{"key":"10.1016\/j.jpsychires.2024.01.002_bib21","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0163-7258(01)00165-6","article-title":"Alteration of drug biotransformation and elimination during infection and inflammation","volume":"92","author":"Renton","year":"2001","journal-title":"Pharmacol. Therapeut."},{"key":"10.1016\/j.jpsychires.2024.01.002_bib22","doi-asserted-by":"crossref","first-page":"235","DOI":"10.2174\/1389200043335559","article-title":"Cytochrome P450 regulation and drug biotransformation during inflammation and infection","volume":"5","author":"Renton","year":"2004","journal-title":"Curr. Drug Metabol."},{"key":"10.1016\/j.jpsychires.2024.01.002_bib23","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1517\/17425255.1.4.629","article-title":"Regulation of drug metabolism and disposition during inflammation and infection","volume":"1","author":"Renton","year":"2005","journal-title":"Expet Opin. Drug Metabol. Toxicol."},{"key":"10.1016\/j.jpsychires.2024.01.002_bib24","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1055\/a-0869-8053","article-title":"Pathological concentration of C-reactive protein is correlated to increased concentrations of quetiapine, but not of risperidone, olanzapine and aripiprazole in a naturalistic setting","volume":"53","author":"Scherf-Clavel","year":"2020","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.jpsychires.2024.01.002_bib25","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1124\/dmd.114.061093","article-title":"Inflammation-induced phenoconversion of polymorphic drug metabolizing enzymes: hypothesis with implications for personalized medicine","volume":"43","author":"Shah","year":"2015","journal-title":"Drug Metabol. Dispos.: Biol. Fate. Chem."},{"key":"10.1016\/j.jpsychires.2024.01.002_bib26","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1093\/eurheartj\/ehaa1103","article-title":"C-reactive protein and clinical outcomes in patients with COVID-19","volume":"42","author":"Smilowitz","year":"2021","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.jpsychires.2024.01.002_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107627","article-title":"Inflammation is a major regulator of drug metabolizing enzymes and transporters: consequences for the personalization of drug treatment","volume":"215","author":"Stanke-Labesque","year":"2020","journal-title":"Pharmacol. Therapeut."},{"key":"10.1016\/j.jpsychires.2024.01.002_bib28","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.ejim.2006.02.025","article-title":"Extremely elevated C-reactive protein","volume":"17","author":"Vanderschueren","year":"2006","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.jpsychires.2024.01.002_bib29","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0161-5890(01)00042-6","article-title":"Human C-reactive protein: expression, structure, and function","volume":"38","author":"Volanakis","year":"2001","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.jpsychires.2024.01.002_bib30","article-title":"The role of cytochrome P450 enzymes in COVID-19 pathogenesis and therapy","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jpsychires.2024.01.002_bib31","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/YIC.0000000000000366","article-title":"Infection is associated with elevated serum concentrations of antipsychotic drugs","volume":"36","author":"Zhang","year":"2021","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2024.01.002_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222312808","article-title":"Cytochrome P450 enzymes and drug metabolism in humans","volume":"22","author":"Zhao","year":"2021","journal-title":"Int. J. Mol. Sci."}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395624000025?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395624000025?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T03:55:07Z","timestamp":1731470107000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395624000025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":32,"alternative-id":["S0022395624000025"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2024.01.002","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relationship between C-reactive protein and antipsychotics levels in schizophrenic patients infected with COVID-19","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychiatric Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychires.2024.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}